Novabay Pharmaceuticals Inc 1 éves cél
Mi az Novabay Pharmaceuticals Inc 1 éves cél?
A 1 éves cél az Novabay Pharmaceuticals Inc - $3 +446.63%
Mi a 1 éves cél meghatározása?
Az 1 évre szóló cél az előrejelzett tőzsdei ár egy év múlva.
One year target is an estimate of a stock price for a point in time equal to a year from the current date. The price level most often reflects the collective opinion of different analysts on where the stock will be trading a year from now. For an analyst to identify an individual estimate, they have to project what a company’s business will look like in a year, typically focusing on revenue and other significant factors. They also consider the willingness of investors to pay a certain price. While the average or median recommendation may be predictive and reflect the actual future value, the results are usually not extremely successful.
1 éves cél a Health Care szektor a NYSEMKT-on cégekben a Novabay Pharmaceuticals Inc -hoz képest
Mit csinál Novabay Pharmaceuticals Inc?
novabay pharmaceuticals $nby is a biopharmaceutical company focusing, commercializing and developing its non-antibiotic anti-infective products to address the unmet therapeutic needs of the global eye care market. novabay has two distinct product categories: the neutrox™ family of products, led by avenova™ for the eye care market, neutrophase® for wound care, and cellerx™ for the dermatology market; and aganocide® compounds, led by auriclosene™. novabay is commercializing avenova, a prescription lid and lash hygiene product for the management of the chronic eye conditions of blepharitis and meibomian gland dysfunction – also known as dry eye syndrome. these difficult-to-manage conditions affect approximately 30 million americans, with an annual market potential that novabay estimates at $500 million. novabay is gaining market traction with avenova through its 35-medical direct sales representatives under veteran leadership. avenova is available for order in 90% of all pharmacies across
1 éves cél -hoz hasonló cégek Novabay Pharmaceuticals Inc
- Atlas Mara nak 1 éves cél $3 +3,461.64% van
- Dundee nak 1 éves cél CAD$3 +96.97% van
- Sinopec Kantons nak 1 éves cél HKD$3 -37.20% van
- Costa nak 1 éves cél AUD$3 -18.50% van
- Minehub Technologies nak 1 éves cél CAD$3 +982.43% van
- Tokentus Investment Ag nak 1 éves cél €3 +216.36% van
- Novabay Pharmaceuticals Inc nak 1 éves cél $3 +446.63% van
- EyePoint Pharmaceuticals Inc nak 1 éves cél $3 -68.00% van
- United Labels AG nak 1 éves cél €3 +47.75% van
- Sonaecom SGPS SA nak 1 éves cél €3 +4.37% van
- Niobay Metals nak 1 éves cél CAD$3 +3,657.14% van
- NeuroOne Medical Technologies nak 1 éves cél $3 +219.95% van
- Potbelly Corp nak 1 éves cél $3 -65.67% van